The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2023

Filed:

Jul. 23, 2021
Applicants:

Health Research, Inc., Menands, NY (US);

Arizona Board of Regents on Behalf of the University of Arizona, Tucson, AZ (US);

Board of Regents, the University of Texas System, Austin, TX (US);

Inventors:

Hongmin Li, Tucson, AZ (US);

Zhong Li, Tucson, AZ (US);

Jia Zhou, League City, TX (US);

Jimin Xu, Galveston, TX (US);

Qing-Yu Zhang, Tucson, AZ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5375 (2006.01); C07D 265/30 (2006.01); C07C 233/75 (2006.01); C07D 211/46 (2006.01); A61P 31/14 (2006.01); C07D 409/12 (2006.01); C07D 213/75 (2006.01); C07D 333/54 (2006.01);
U.S. Cl.
CPC ...
C07D 265/30 (2013.01); A61P 31/14 (2018.01); C07C 233/75 (2013.01); C07D 211/46 (2013.01); C07D 213/75 (2013.01); C07D 333/54 (2013.01); C07D 409/12 (2013.01);
Abstract

The present disclosure relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. The present disclosure further relates to methods of inhibiting viral replication including contacting one or more cells that have been infected with a virus with an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the virus comprises a flavivirus. Also disclosed is a method of treating and/or preventing a flavivirus infection and/or a condition resulting from a flavivirus infection including administering an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof under conditions effective to treat and/or prevent a flavivirus infection and/or a condition resulting from a flavivirus infection.


Find Patent Forward Citations

Loading…